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The Locomotor Experience Applied Post Stroke rehabilitation trial found equivalent walking 
outcomes for body weight-supported treadmill plus overground walking practice versus home-
based exercise that did not emphasize walking. From this large database, we examined several 
clinically important questions that provide insights into recovery of walking that may affect future 
trial designs. Using logistic regression analyses, we examined predictors of response based on a 
variety of walking speed-related outcomes and measures that captured disability, physical 
impairment, and quality of life. The most robust predictor was being closer at baseline to the 
primary outcome measure, which was the functional walking speed thresholds of 0.4 m/s 
(household walking) and 0.8 m/s (community walking). Regardless of baseline walking speed, a 
younger age and higher Berg Balance Scale score were relative predictors of responding, whether 
operationally defined by transitioning beyond each speed boundary or by a continuous change or a 
greater than median increase in walking speed. Of note, the cutoff values of 0.4 and 0.8 m/s had 
no particular significance compared with other walking speed changes despite their general use as 
descriptors of functional levels of walking. No evidence was found for any difference in predictors 
based on treatment group.
Clinical Trial Registration—ClinicalTrials.gov; NCT00243919, “Locomotor Experience 
Applied Post Stroke Trial”; http://www.clinicaltrials.gov
Keywords
community ambulation; exercise; functional walking level; gait speed; LEAPS; outcome 
measures; physical therapy; quality of life; stroke rehabilitation; walking
INTRODUCTION
Single, randomized controlled clinical trials (RCTs) are far from the perfect instrument to 
determine the efficacy of a new therapeutic intervention [1]. The results of stroke 
rehabilitation trials can be especially challenging to interpret, partly because the level of 
impairment in the comparison groups, the components of the intervention, and the relevance 
of outcome measurement tools to the intervention bear complex interrelationships [2]. Even 
if a trial shows equivalence for different treatments, clinicians may ask whether a subgroup 
of participants was especially responsive [3]. The underlying concern is that a particular 
type of rehabilitation training may not have a uniform effect, so participants who fall into 
separable subgroups may experience differential responses to each RCT intervention. 
Observational practice-based evidence is another method that aims to examine the 
heterogeneity of responses outside of a formal trial [4]. Between-subgroup differences and 
within-subgroup similarities, however, are usually identifiable only by post hoc analysis, 
with its inherent statistical confounds [5]. Regression analyses are the most robust approach 
to assessing what has been called the heterogeneity effect [6]. They can capture the 
likelihood that patients differ from one another in multiple variables simultaneously. The 
establishment of baseline predictors of response to a particular therapy for walking 
impairment after stroke could aid clinical decisions as to whether or not to employ that 
therapy. It could also inform future stroke rehabilitation research.
A related question is whether the optimal outcome measurement tool was employed as the 
primary outcome for the RCT [7]. For a complex physical intervention, which is typical of 
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most neurorehabilitation trials, a single measurement may not be adequate to reveal 
differential effects on impairment, disability, activity, and participation [8–9]. This issue can 
also be addressed by secondary analyses of a large database.
The Locomotor Experience Applied Post Stroke (LEAPS) RCT randomized 408 participants 
2 mo after a hemiparetic stroke to two conceptually different physical therapy interventions 
to test for efficacy of one over the other in improving walking-related outcomes [10]. 
Participants were stratified to a severe impairment group if baseline speed was <0.4 m/s or 
to a moderate impairment group if speed was 0.4 to 0.8 m/s. Prior research suggested that 
these walking speeds are associated with home-only and limited community ambulation, 
respectively [11–13]. The primary outcome measurement in LEAPS was the proportion of 
participants in each treatment group that transitioned to a higher functional level of walking 
(>0.4 m/s for the severe group >0.8 m/s for the moderate group). The trial revealed that the 
two interventions were equally efficacious [10,14].
In this series of secondary analyses, we addressed several clinically meaningful questions. 
First, we asked whether any baseline variables predicted whether a participant would 
transition to a higher functional walking level. Second, because a transition might not be the 
optimal measure of improvement, we asked whether any baseline variables predicted 
favorable responses as defined by tools commonly used in stroke trials, including changes in 
walking speed, greater than median gains in walking speed and step counts, and subscale 
scores on the Stroke Impact Scale (SIS) [15], which might plausibly correlate with quality of 
life associated with mobility. Third, we asked to what extent the transition to a higher 
functional walking level was associated with gains in SIS subscale scores that seem relevant 
to walking. Finally, we sought to determine whether the highly regarded transition 
boundaries chosen for the LEAPS trial (0.4 and 0.8 m/s) had intrinsic clinical significance in 
terms of their relationship to changes in SIS subscale scores or whether the significance of 
the boundaries lay solely in their relationship to progressive increments in walking speed. 
Because participants with different baseline attributes might have responded differentially to 
the type and timing of the LEAPS interventions, we looked for interaction effects between 
treatment arm and predictor variables.
METHODS
Locomotor Experience Applied Post Stroke Trial
The LEAPS trial was a multicenter, single-blind RCT that compared a Locomotor Training 
Program (LTP) delivered at 2 mo (early-LTP [E-LTP]) or 6 mo (late-LTP [L-LTP]) 
poststroke in an outpatient facility with a Home Exercise Program (HEP) delivered at 2 mo 
at the participant’s home. LTP included stepping on a treadmill with partial body weight-
support for 20 to 30 min at 0.89 m/s and manual assistance as needed, followed by 
progressive overground training for 15 min, provided by a physical therapist and up to two 
rehabilitation technicians. HEP included progressive flexibility, joint range of motion, 
upper-limb (UL) and lower-limb (LL) strengthening, coordination, and static and dynamic 
balance exercises provided by a physical therapist in the home. No specific walking activity 
was undertaken in the HEP protocol. In addition to the LTP and HEP interventions, all 
participants could receive prescribed customary care. The LTP and HEP programs were 
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controlled for exercise frequency (90 min sessions, 3 times per week) and duration (12 to 16 
wk) over 30 to 36 sessions. At the time of randomization, participants had residual paresis in 
the LL, could walk 10 ft with no more than one-person assistance, and had a self-selected 10 
m walking speed of less than 0.8 m/s.
The LEAPS protocol and primary outcomes have been reported [10,16]. Participants were 
randomized 63.8 ± 8.5 d poststroke; 53.4 percent walked <0.4 m/s and 46.6 percent walked 
0.4 to 0.79 m/s. At 12 mo, 52 percent of all participants had increased functional walking 
ability, as defined by transitioning beyond a boundary, but no significant differences were 
found between the effects of E-LTP, L-LTP, and HEP. Mean walking speed at that time was 
approximately 0.24 m/s higher than at baseline.
Statistical Analysis
Predictors of a transition were identified based on univariate and multivariate logistic 
regression analyses with backward selection of predictors. Potential interaction effects 
between the selected predictors and training group were examined to test whether 
participants with different baseline attributes responded differentially to the treatments. The 
dependent variable was whether a participant transitioned from one level of walking ability 
to a higher one. The independent variables, assessed at baseline (2 mo poststroke), included 
demographic measures (age, sex), training group (E-LTP, L-LTP, and HEP), side of lesion, 
impairment severity (moderate or severe), baseline walking speed difference from 0.4 or 0.8 
m/s for the two severity groups, National Institutes of Health Stroke Scale (NIHSS), Fugl-
Meyer (F-M) LL and UL scores, Berg Balance Scale (BBS) score, modified Rankin Scale 
(mRS) score, and difference between the times to complete part B and part A of the Trail 
Making test. Need for rehospitalization and serious adverse events during the trial were 
included as independent variables.
We also conducted logistic regression analyses to identify predictors of response defined by 
a greater than median change in walking speed, SIS participation score, SIS activities of 
daily living/instrumental activities of daily living (ADL/IADL) score, and SIS mobility 
score. Furthermore, we performed a linear regression analysis, employing the same predictor 
variables, to identify predictors of gains in continuous walking speed. We used t-tests to 
compare SIS subscale scores, F-M domain scores, total steps as determined by an inertial 
step activity monitor, BBS, and Activities-Specific Balance Confidence (ABC) scale scores 
between responders and nonresponders as defined by transition beyond a boundary. Finally, 
to seek evidence of whether the boundary values of 0.4 and 0.8 m/s had intrinsic ecological 
validity, validity that might differ as a function of baseline walking speed, we plotted several 
SIS measures (rating of ability to walk a block, and ADL/IADL, mobility, and participation 
scale scores) as a function of walking speed at 12 mo poststroke for each baseline walking 
speed from 0 to 0.8 m/s in 0.1 m/s increments. No statistical corrections were made for 
multiple comparisons.
RESULTS
The mean walking speed change for the 212 responders (those who achieved a transition) 
was 0.39 ± 0.17 m/s and 0.08 ± 0.13 m/s for nonresponders (p < 0.001).
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Predictors of Transitioning to Higher Functional Walking Level
Table 1 shows that the smaller the difference between baseline walking speed and each of 
the boundary values (0.4 and 0.8 m/s for severe and moderate groups, respectively), the 
greater the likelihood of transitioning past that boundary. This nearness-to-the-boundary 
benefit was found for pooled data and for each intervention. Specifically, for every 
increment of 0.1 m/s between baseline walking speed and a boundary value, the odds ratio 
(OR) of transitioning to a higher functional level of walking decreased by 66 percent. This 
was the most robust predictor. Other individual predictors for transitioning were lower age 
(>50% probability if below 60 yr, Figure 1) and NIHSS score, BBS score (>50% probability 
if >40 points, Figure 1), and higher F-M LL and UL scores and mRS score, as well as the 
absence of recurrent hospitalization. For every increment of 1 yr in age, the OR for a 
successful transition decreased by 5 percent. For every increment of 1 point in the BBS 
score, the OR increased by 7 percent. For every increment of 1 point in NIHSS score (lower 
scores mean less impairment), the OR decreased by 9 percent. For every increment of 1 
point in F-M LL score, the OR increased by 7 percent. Thus, better baseline motor function 
was associated with better walking outcomes. The odds of a transition for those with a mRS 
score < 3 were 2.9 times those with an mRS score ≥ 3 at baseline. Participants who were not 
hospitalized and had no serious adverse events over the course of the RCT were 4.2 times 
more likely to transition. However, in our multivariate logistic regression with backward 
selection, only the baseline-to-boundary speed difference, age, and BBS score remained 
significant. Finally, there were no significant interactions between these predictors and 
intervention group (p > 0.05).
Predictors of Response Defined by Other Variables
Table 2 shows the results of logistic regression analyses of predictors for responders defined 
by greater than a median change in walking speed, SIS participation score, SIS ADL/IADL 
score, or SIS mobility score. Lower age and higher BBS score were found to be significant 
predictors (p < 0.001) of a better outcome defined by greater than a median gain in walking 
speed. No variables predicted a greater than median change in SIS participation or ADL/
IADL score. With the single exception of the relation between L-LTP and SIS mobility scale 
score (p = 0.03, uncorrected for multiple comparisons), no significant interactions between 
predictors and intervention group were found.
We also conducted a linear regression analysis to identify predictors of gain in continuous 
walking speed over the course of the trial. Age and BBS were again significant predictors, as 
were rehospitalization and the difference between Trail Making Tests B and A.
Of participants who achieved a greater than median gain in walking speed, 86 percent 
crossed a transition boundary. Of participants who achieved less than a median gain, 82 
percent did not cross a transition boundary, regardless of the intervention. Thus, 
transitioning past a boundary and achieving a greater than median change in walking speed 
seemed to tap the same fundamental walking variable.
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Possible Clinical Meaning of Transitioning: Stroke Impact Scale Results
Table 3 compares the SIS domains and other outcome measurements between participants 
who successfully transitioned to higher functional walking speeds with those who did not. 
Participants who did transition, regardless of initial walking level category or treatment 
group, had larger improvements in the SIS ADL/IADL (p = 0.01), hand function (p < 
0.001), and recovery (p < 0.001) domains, as well as higher gains in F-M UL score (p < 
0.001), total steps walked per day (p < 0.001), and ABC scores (p < 0.001). Participants in 
the moderate group who transitioned also showed greater gains in SIS participation score (p 
= 0.048).
In the severe impairment group, response as defined by a greater than median gain in 
walking speed was also associated with greater SIS ADL/IADL and higher SIS participation 
scores. In the most severely impaired group (baseline speed 0–0.1 m/s), walking speed 
increases achieved by 1 yr were associated with particularly large increases in self-reported 
SIS mobility score.
Ecological Validity of 0.4 and 0. 8 m/s Boundaries
The preceding analyses suggested that transitioning past a 0.4 or 0.8 m/s boundary did 
correspond to changes in walking ability that might affect quality of life. In the following 
analyses, we sought to determine whether the predefined transition boundaries of 0.4 and 0.8 
m/s had particular significance in their relationship to measures related to quality of life, as 
has been suggested in the literature. Alternatively, these boundaries might derive their 
significance solely from their relationship to the magnitude of gain in walking speed.
Figure 2 shows a plot of SIS item 6e (self-rated difficulty in walking a block) versus 
walking speed at 12 mo, stratified by baseline walking speed in bins of 0.1 m/s at baseline. 
We selected this item as an alternative outcome because this self-perception may especially 
reflect the potential to participate in community activities. Faster walking speed was 
associated with less difficulty walking a block. However, visual inspection does not suggest 
that the cutoff values of 0.4 and 0.8 m/s that had previously been associated with home 
versus community walking levels have particular significance. Rather, the ability to walk a 
block bears a more or less linear relationship to walking speed. This linear relationship held 
for all other SIS subscales tested (ADL/IADL, mobility, and participation), and in no case 
was there evidence of a step at 0.4 or 0.8 m/s.
Inspection of Figure 2 also reveals self-reports of walking one block being rated “not 
difficult at all” or “only a little difficult” despite low walking speed (<0.4 m/s) or being rated 
“very difficult” despite high walking speed (>0.8 m/s). At least 22 subjects reported the 
former (lowest walking speed bins, left column) and 4 reported the latter (right column).
DISCUSSION
The single strongest predictor of whether a participant had transitioned at 12 mo beyond the 
trial’s boundaries of 0.4 and 0.8 m/s was how close the participant had been to a boundary at 
baseline (2 mo after stroke). The slowest walkers in each of the two severity groups, of 
course, had to make greater gains on the 10 m walk than participants who walked faster at 
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baseline to achieve a transition. The mean gain in walking speed across the two severity 
groups and the three interventions was approximately 0.24 m/s, which was not enough for 
the initially slowest walkers to transition past a boundary. Thus, both interventions had a 
ceiling effect. Another apparent limitation of both interventions was that only 15 
participants, nearly all of whom walked >0.4 m/s at baseline, achieved a walking speed ≥1.2 
m/s, which begins to approach the speed of nondisabled age-matched persons.
Older participants and participants who had a lower BBS score were less likely to transition 
past a boundary (Figure 1) regardless of treatment group. Greater age and lower BBS score 
were also the only consistent predictors of response defined in other ways, such as 
exceeding the median increase in walking speed at 12 mo or having a greater increase in 
walking speed. Thus, we did not identify an outcome measurement related to walking speed 
that would have distinguished responders from nonresponders differently than our boundary 
criteria for a functional transition. This finding was true for the pooled data and for each 
intervention.
These findings suggest several conclusions. First, although age and BBS score do not 
provide the basis for sharp distinctions between those who are more or less likely to respond 
to the types of treatment used in LEAPS, our findings do suggest that they could influence 
clinical decision-making. This suggestion is most clearly illustrated in Figure 1. Drawing 
from these data, clinicians and patients might conclude that the probability of a favorable 
response at advanced age and low BBS score is just too low to justify engagement in these 
intensive treatments. Second, more precise prediction of response will likely require 
measurement of additional variables that reflect yet undefined neurobiological mechanisms 
of recovery, along with the dynamic personal characteristics of participants as they interact 
with their support systems and perform in the community. Third, the potential for different 
baseline attributes to predict differential response to type of treatment received no support 
from our analyses.
Stroke Impact Scale Results
We had posited that useful baseline predictors of response might emerge more clearly if we 
defined response in terms of variables such as the SIS ADL/ IADL, mobility, or 
participation scales; self-reported ability to walk a block (SIS item 6e); or measures derived 
from the step activity monitor. This hypothesis was not supported. In part, this appeared to 
be a consequence of greater than anticipated variability in the SIS subscale reports. For 
example, we found 16 participants at baseline and 22 at 12 mo with walking speeds ≤0.4 m/s 
who scored at 80 percent on SIS mobility, claiming little or no difficulty (Figure 2). Values 
for SIS item 6e (Figure 2), as noted, reveal instances of intuitive discrepancies—very low 
speed yet little difficulty walking a block and high walking speed but much difficulty. Thus, 
a remarkable number of participants who started with very slow walking speeds and did not 
transition nonetheless reported high levels of functional mobility. The discrepancy could 
arise from other illness or personal issues but may represent a recalibration of response, i.e., 
a change in internal standards of measurement [17]. The SIS, like other health-related 
quality of life instruments, is also a complex tool that may allow for too much 
interindividual variability, despite its reported ability to detect clinically important 
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differences [15]. Subjective and objective measures of participation have also been weakly 
associated in other studies [18].
Functional Walking Speed Levels
The LEAPS trial chose walking speed boundaries that represented an important change 
based on the results of smaller trials and observational studies [13]. These speed transitions 
are considered to be meaningful goals for clinical care and as trial outcomes [19]. 
Participants who transitioned did indeed have greater improvements across our secondary 
measures. While our analyses do not suggest that the threshold values of 0.4 and 0.8 m/s 
have particular ecological meaning in and of themselves, they do show that transcending 
these thresholds bore a high correspondence to other measures of response, such as greater 
than median gain in walking speed. Increases in walking speed were generally associated 
with better self-reported quality of life, to the extent that it is reflected in the SIS ADL/
IADL, mobility, and participation scores. Thus, simply walking faster confers advantages.
The LEAPS boundaries for functional walking ability derive from an early report that 0.4 
m/s serves as a threshold between household walking and the potential for community 
walking [12]. These findings were based on responses to SIS physical functioning types of 
questions, not real-world observations, at 3 mo poststroke by 147 patients who had been in 
stroke rehabilitation at one site. At 0.2 to 0.3 m/s, subjects in the study moved from limited 
to unlimited home walking. At 0.6 to 0.8 m/s, they moved from least limited to community-
level walking. Functional ambulation self-report items, however, were in agreement with 
walking velocity categories only 44 percent of the time. LL strength was more discerning. 
The combination of walking speed and control of knee extension differentiated household 
from community walkers with 78 percent agreement. Thus, gait speed boundaries, alone, 
have perhaps been given too much weight as an outcome for clinical trials. As Perry et al. 
noted, the capacity for limited or full community ambulation reflects factors beyond gait 
speed, including the ability to negotiate uneven surfaces, curbs, and obstacles, as well as 
psychological and environmental interactions that may not be captured by gait speed alone, 
particularly on a flat laboratory walkway [12].
Methodological Limitations
Our responder versus nonresponder analysis is intrinsically limited by its post hoc nature 
and must be interpreted cautiously given the multiple uncorrected comparisons [6]. We also 
were limited to the predictor variables that we collected, although these were typical of trials 
that aim to improve walking after stroke.
Our primary outcome measure and the basis for this study’s 0.4 and 0.8 m/s boundaries was 
the 10 m timed walk carried out in a laboratory setting. This task, although frequently used 
in stroke trials, may not reflect the context and demands of walking in the home and 
community. Continuous monitoring of type, quantity, and quality of daily walking for 
practice, exercise, and travel could improve the validity of trials of walking interventions, 
especially by detecting all that participants do, i.e., the actual dose of formal and informal 
exercise and practice. Emerging techniques, employing triaxial accelerometry data analyzed 
by activity-recognition algorithms and managed by wireless transmission, are proving 
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capable of remotely measuring bouts of walking or cycling speed, duration, and distance 
with great precision [20–23]. Thus, actual performance parameters could supplement the 
laboratory tasks, ordinal scales, and self-reports used in LEAPS and most rehabilitation 
trials.
CONCLUSIONS
Although we did not find baseline variables that sharply distinguished between those who 
would or would not respond to the trial interventions, lower age and higher BBS score had a 
sufficient influence on response to provide some basis for clinical decision-making about 
employing the LEAPS interventions. Closeness of individual walking speed to a transition 
point was the strongest predictor of transition across a boundary, but this finding reflected 
the fact that the further a participant was from a boundary, the greater the improvement in 
gait speed necessary to achieve a transition.
There was a striking lack of association between perceived walking ability and gait speed. 
We found no evidence of a differential relationship between baseline predictor variables and 
treatment group effect. The walking speed-related functional boundaries we chose appeared 
to be less ecologically meaningful than anticipated. More sophisticated predictor variables 
appear to be needed to sufficiently capture the complex relationship between the individual 
participant and therapeutic response. Along with seeking efficacious walking interventions 
for the person with more hemiparetic impairment, better measures of response are needed. 
The combination of quality of life and disability scales may not be sophisticated enough. 
Community-based measures of actual performance may more fully measure rehabilitation 
outcome, as well as quantify therapeutic activity by patients outside of the formal therapies 
being tested.
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Figure 1. 
Probability of transitional leap beyond 0.4 or 0.8 m/s functional walking boundary in 
relation to age and Berg Balance Scale for pooled data from both interventions. Success = 
probability of achieving >median gain in walking speed.
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Figure 2. 
Plot of Stroke Impact Scale item 6e (self-rated difficulty in walking a block) by walking 
speed at 12 mo follow-up of all participants, stratified by baseline walking speed in bins of 
0.1 m/s. n = number of participants in that bin. Vertical broken line shows baseline speed 
(left) and functional walking speed boundary (right). SIS scoring: 5 = not difficult, 4 = a 
little difficult, 3 = somewhat difficult, 2 = very difficult, 1 = cannot do.
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Table 2
Predictors of response defined as greater than median changes in walking speed and other outcomes.
Responder Defined By Variable Odds Ratio 95% CI p-Value
Walking Speed Change Age 0.95 0.94–0.97 <0.001
Berg Balance Scale 1.04 1.03–1.06 <0.001
SIS Participation Change None — — —
SIS ADL/IADL Change None — — —
SIS Mobility Change Group E-LTP vs HEP 0.69 0.39–1.24 0.21
Group L-LTP vs HEP 0.52 0.29–0.93 0.03
Age 0.97 0.96–0.99 0.01
Sex Male vs Female 0.48 0.29–0.78 0.004
Berg Balance Scale 0.97 0.95–0.99 0.01
Stroke Location Left vs Right 1.88 1.15–3.08 0.01
Modified Rankin Scale 0–2 vs 3–5 0.31 0.14–0.68 0.003
Trail Making Test Change 1.003 1.000–1.006 0.03
ADL/IADL = activities of daily living/instrumental activities of daily living, CI = confidence interval, E-LTP = early-Locomotor Training 
Program, HEP = Home Exercise program, L-LTP = late-Locomotor Training Program, SIS = Stroke Impact Scale.
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Table 3
Comparison of Stroke Impact Scale (SIS) subscale scores and other outcomes between responders, defined by 
transition across walking speed boundary, and nonresponders.
Variable Overall Responders Nonresponders p-Value
SIS
Participation
 Baseline 45.5 ± 23.3 48.0 ± 22.7 42.8 ± 23.5 0.02
 12 mo 60.0 ± 24.0 64.1 ± 22.5 55.0 ± 24.9 <0.001
 Change 14.8 ± 23.0 16.6 ± 22.2 12.6 ± 23.9 0.11
Mobility
 Baseline 58.9 ± 20.8 63.7 ± 18.9 53.7 ± 21.5 <0.001
 12 mo 72.7 ± 19.0 79.5 ± 14.7 64.3 ± 20.4 <0.001
 Change 13.3 ± 20.3 15.1 ± 19.3 11.0 ± 21.4 0.06
Strength
 Baseline 42.9 ± 21.0 45.3 ± 20.8 40.3 ± 20.9 0.02
 12 mo 49.5 ± 22.8 53.0 ± 21.1 45.2 ± 24.1 0.001
 Change 6.4 ± 21.6 7.8 ± 20.2 4.7 ± 23.3 0.16
Memory
 Baseline 81.5 ± 19.9 82.0 ± 19.8 80.9 ± 20.1 0.56
 12 mo 80.5 ± 20.9 81.9 ± 20.3 78.8 ± 21.6 0.16
 Change −1.3 ± 17.9 −0.9 ± 17.5 −1.9 ± 18.5 0.62
Emotion
 Baseline 63.1 ± 12.2 62.4 ± 12.2 63.8 ± 12.2 0.24
 12 mo 61.8 ± 12.2 62.5 ± 11.8 61.0 ± 12.7 0.25
 Change −0.9 ± 14.1 0.3 ± 11.8 −2.3 ± 16.4 0.08
Communication
 Baseline 84.7 ± 20.0 85.8 ± 19.2 83.5 ± 20.7 0.23
 12 mo 86.1 ± 17.5 87.9 ± 16.1 83.8 ± 18.8 0.03
 Change 1.0 ± 13.8 2.0 ± 13.7 0.2 ± 13.8 0.15
ADL/IADL
 Baseline 54.7 ± 20.4 59.4 ± 18.6 49.7 ± 21.1 <0.001
 12 mo 66.5 ± 20.2 73.1 ± 17.0 58.2 ± 20.9 <0.001
 Change 11.1 ± 18.7 13.5 ± 17.5 8.1 ± 19.7 0.01
Hand Function
 Baseline 24.1 ± 28.3 26.0 ± 28.2 22.0 ± 28.4 0.15
 12 mo 37.7 ± 33.7 44.2 ± 33.7 29.7 ± 32.0 <0.001
 Change 13.2 ± 25.5 18.2 ± 25.9 7.1 ± 23.6 <0.001
Recovery
 Baseline 46.8 ± 21.9 49.1 ± 19.4 44.2 ± 24.2 0.02
 12 mo 60.1 ± 22.1 65.7 ± 19.2 53.1 ± 23.4 <0.001
 Change 12.6 ± 20.6 16.5 ± 19.7 7.7 ± 20.8 0.001
Fugl-Meyer
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Variable Overall Responders Nonresponders p-Value
Motor
 Baseline 58.3 ± 25.3 62.3 ± 23.7 54.0 ± 26.3 0.01
 12 mo 67.6 ± 24.5 73.4 ± 21.5 60.4 ± 26.0 <0.001
 Change 8.6 ± 11.9 11.2 ± 12.8 5.4 ± 9.9 <0.001
Upper Limb
 Baseline 34.0 ± 20.7 36.8 ± 19.8 30.9 ± 21.2 <0.001
 12 mo 41.3 ± 20.1 45.7 ± 18.2 36.0 ± 21.2 <0.001
 Change 6.8 ± 9.9 9.1 ± 10.8 3.9 ± 8.0 <0.001
Lower Limb
 Baseline 24.4 ± 6.4 25.7 ± 5.8 23.1 ± 6.8 <0.001
 12 mo 26.3 ± 5.8 27.9 ± 4.7 24.4 ± 6.5 <0.001
 Change 1.9 ± 4.0 2.2 ± 3.9 1.5 ± 4.0 0.11
SAM Total Steps
Baseline (mean ± SD) 2,551.7 ± 2,569.7 3,074.0 ± 2,800.2 1,972.0 ± 2,150.1 <0.001
Baseline (median [Q1, Q3]) 1,738.5 [708.0, 3,482.5] 2,267.5 [1,127.0, 4,343.0] 1,219.0 [453.0, 2,772.0]
12 mo (mean ± SD) 4,294.3 ± 3,464.0 5,403.2 ± 3,506.1 2,959.0 ± 2,905.7 <0.001
12 mo (median [Q1, Q3]) 3,695.0 [1,843.0, 6,057.0] 4,791.0 [2,822.0, 7,646.0] 2,301.5 [798.0, 4,196.0]
Change (mean ± SD) 1,665.8 ± 3,082.5 2,306.6 ± 3,337.0 877.8 ± 2,535.2 0.001
Change (median [Q1, Q3]) 1,097.0 [−1.0, 3,054.0] 1,849.5 [511.0, 3,672.0] 435.0 [−265.0, 1,609.0]
Berg Balance Scale
Baseline 35.8 ± 14.0 41.0 ± 10.4 30.1 ± 15.2 <0.001
12 mo 43.7 ± 11.4 49.2 ± 5.7 37.0 ± 13.0 <0.001
Change 7.4 ± 8.6 7.9 ± 7.7 6.8 ± 9.6 0.26
ABC Score
Baseline 45.1 ± 23.9 49.2 ± 22.7 40.6 ± 24.3 <0.001
12 mo 57.6 ± 25.6 66.5 ± 21.6 46.6 ± 25.9 <0.001
Change 12.3 ± 22.0 16.8 ± 20.7 6.5 ± 22.3 <0.001
ABC = Activities-Specific Balance Confidence, ADL/IADL = activities of daily living/instrumental activities of daily living, Q1 = first quintile, 
Q3 = third quintile, SAM = step activity monitor.
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